Lora Humphrey Beebe, PhD, APRN, BC, is Associate Professor, College of Nursing, University of Tennessee, Knoxville, TN.
Obesity in Schizophrenia: Screening, Monitoring, and Health Promotion
Version of Record online: 26 DEC 2007
Perspectives in Psychiatric Care
Volume 44, Issue 1, pages 25–31, January 2008
How to Cite
Beebe, L. H. (2008), Obesity in Schizophrenia: Screening, Monitoring, and Health Promotion. Perspectives in Psychiatric Care, 44: 25–31. doi: 10.1111/j.1744-6163.2008.00144.x
- Issue online: 26 DEC 2007
- Version of Record online: 26 DEC 2007
- Antipsychotic medications;
- lifestyle interventions;
PURPOSE.This paper reviews risks, assessments, antipsychotic medication choices, and lifestyle interventions for obesity in persons with schizophrenia.
CONCLUSIONS. Antipsychotic medication is the most important treatment choice. Simple diet teaching must take into account the cognitive limitations of clients with schizophrenia. After medical clearance is obtained, moderate exercise can be encouraged. Education about exercise benefits may increase motivation.
PRACTICE IMPLICATIONS. Nurses would be remiss to ignore the physical health effects of obesity in schizophrenia. Practitioners must choose psychiatric medications and provide health education, health promotion, and appropriate referrals to optimize quality of life for this group.